欧洲戒烟和尼古丁戒瘾市场 – 行业趋势和 2031 年预测

请求目录 请求目录 与分析师交谈 与分析师交谈 立即购买 立即购买 购买前请咨询 提前咨询 免费样本报告 免费样本报告

欧洲戒烟和尼古丁戒瘾市场 – 行业趋势和 2031 年预测

  • FMCG
  • Upcoming Report
  • Mar 2024
  • Europe
  • 350 页面
  • 桌子數: 220
  • 图号: 60

>欧洲戒烟和尼古丁脱瘾市场,按产品类型(尼古丁替代治疗产品、药物治疗、电子香烟等)、治疗类型(药理学、疗法等)、形式(口香糖、吸入器、药片等)、分销渠道(线上和线下)、最终用户(Z 世代、千禧一代、X 世代和沉默的一代)划分 - 行业趋势和预测到 2031 年。

欧洲戒烟和尼古丁戒瘾市场

欧洲戒烟和尼古丁戒瘾市场分析及规模

戒烟和尼古丁戒瘾市场提供各种应用,包括药物、尼古丁替代疗法和行为疗法,帮助人们戒烟。用于跟踪进度的移动应用程序和虚拟支持小组等创新技术提高了戒烟效果。这个市场满足了对抗尼古丁成瘾的有效解决方案的迫切需求。

Data Bridge Market Research 分析称,2023 年欧洲戒烟和尼古丁戒瘾市场价值为 177 亿美元,预计到 2031 年将达到 1075.7 亿美元,在 2024-2031 年预测期内的复合年增长率为 25.3%。除了市场价值、增长率、细分市场、地理覆盖范围、市场参与者和市场情景等市场洞察外,Data Bridge Market Research 团队策划的市场报告还包括深入的专家分析、进出口分析、定价分析、生产消费分析和消费者行为。

报告范围和市场细分

报告指标

细节

预测期

2024 至 2031 年

基准年

2023

历史岁月

2022 (可定制为 2016 - 2021)

定量单位

收入(单位:十亿美元)、销量(单位:台)、定价(美元)

涵盖的领域

产品类型(尼古丁替代治疗产品、药物治疗、电子香烟等)、治疗类型(药理学、疗法等)、形式(口香糖、吸入器、药片等)、分销渠道(线上和线下)、最终用户(Z 世代、千禧一代、X 世代和沉默的一代)

覆盖国家

德国、瑞典、波兰、丹麦、意大利、英国、法国、西班牙、荷兰、比利时、瑞士、土耳其、俄罗斯、欧洲其他地区

涵盖的市场参与者

Cipla Inc.(印度)、Johnson & Johnson Services, Inc.(美国)、武田药品工业株式会社(日本)、Alkalon A/S(丹麦)、22nd Century Group, Inc.(美国)、葛兰素史克公司(英国)、Imperial Brands plc(英国)、JT International SA(日本)、BAT(英国)、Perrigo Company plc(爱尔兰)、Fertin Pharma(丹麦)、Cambrex Corporation(美国)、Dr. Reddy's Laboratories Ltd.(印度)、辉瑞公司(美国)、Strides Pharma Science Limited(印度)

市场机会

  • 尼古丁成瘾整体戒烟计划不断发展
  • 不断开展无烟生活健康意识宣传活动

市场定义

Smoking cessation and nicotine de-addiction involve interventions and strategies aimed at helping individuals quit smoking and overcome nicotine addiction. This encompasses medical aids, nicotine replacement therapies, behavioral counseling, and support programs. Effective cessation methods are crucial for improving public health and reducing the harmful effects of tobacco use.

Europe Smoking Cessation and Nicotine De-Addiction Market Dynamics

Drivers

  • Rapidly Evolving Social Norms Towards Quitting

Changing societal views on smoking boost demand for cessation aid. Peer pressure and workplace policies advocating smoke-free spaces strengthen cessation attempts. Stigma linked to smoking further propels individuals towards quitting. This shift in norms fosters a surge in seeking support for smoking cessation, reflecting a broader cultural trend towards healthier lifestyles.

  • Government Regulations for Smoking Cessation Products

Government regulations worldwide, such as tobacco taxes, advertising bans, and smoke-free policies, drive demand for smoking cessation products by incentivizing smokers to quit. These stringent policies create a conducive environment for individuals to seek cessation support, contributing to the growth of the smoking cessation and nicotine de-addiction market.

Opportunities

  • Growing Holistic Cessation Programs for Nicotine Addiction

Understanding the psychological and behavioral dimensions of nicotine addiction drives the demand for holistic cessation programs. Counseling, support groups, and digital platforms provide personalized coaching and behavioral therapy, complementing pharmacological treatments. This integrated approach enhances long-term success rates in quitting smoking by addressing underlying psychological factors effectively.

  • Growing Health Awareness Campaigns for Smoke-Free Life

Public health campaigns raise awareness of smoking's health risks such as cancer and heart disease, urging individuals to quit. Highlighting benefits of cessation, these initiatives encourage seeking treatments. Through educating on the dangers and advantages of quitting, they play a pivotal role in motivating smokers to take steps towards a smoke-free life, fostering healthier communities.

Restraints/Challenges

  • Dual Use of Tobacco and Electronic Cigarettes

The dual use of electronic cigarettes alongside traditional cigarettes poses a challenge to the smoking cessation market. While some view e-cigarettes as a cessation aid, they can perpetuate nicotine addiction, hindering efforts to quit altogether. This behavior prolongs dependence on nicotine, reducing the demand for traditional cessation products and impacting the market's growth.

  •  High Relapse Rates in Smoking Cessation

The persistent issue of high relapse rates in smoking cessation presents a formidable obstacle for the market. Existing interventions fall short in delivering lasting outcomes, undermining consumer contentment and hindering the expansion and durability of the smoking cessation and nicotine de-addiction market.

This Europe smoking cessation and nicotine de-addiction market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the Europe smoking cessation and nicotine de-addiction market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Developments

  • In March 2021, Pfizer Inc. expanded its business by developing a supplemental New Drug Application for anaplastic lymphoma kinase treatment. This diversification could boost revenue and indirectly contribute to smoking cessation efforts by strengthening the company's overall financial position
  • In March 2021, Takeda Pharmaceutical Company Limited acquired Maverick Therapeutics, enhancing its tumor therapy and T cell development portfolio. This strategic move support smoking cessation initiatives by bolstering Takeda's resources and potentially funding research in the field
  • In February 2020, Strides Pharma Science Limited, via its subsidiary Strides Consumer Private Limited, entered the market with two over-the-counter products for smoking cessation and joint pain relief. This expansion aligns with addressing health concerns, potentially providing accessible solutions for individuals seeking to quit smoking

Europe Smoking Cessation and Nicotine De-Addiction Market Scope

The Europe smoking cessation and nicotine de-addiction market is segmented on the basis of product type, treatment type, form, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product Type

  • Nicotine Replacement Therepy Products
    • Over-the-Counter
    •  Prescription
  • Drug Therepy
    • Varenicline
    • Zyban
  • E-Cigarettes
    • Modular
    • Disposable
    • Rechargeable
  • Others
    • With Nicotine
    • Without Nicotine

 Treatment Type

  • Pharmacological
  • Therapies
  • Others

  Form

  • Gum
  • Inhaler
  • Tablet
  • Others

 Distribution Channel

  • Online
  • Offline
    • Hospital Pharmacies
    •  Drug stores
    •  Retail Pharmacies

 End-User

  • Generation Z
  • Millennials
  • Generation X
  • Silent Generation

欧洲戒烟和尼古丁脱瘾市场区域分析/见解

对欧洲戒烟和尼古丁脱瘾市场进行了分析,并按上述产品类型、治疗类型、形式、分销渠道和最终用户提供了市场规模洞察和趋势。

欧洲戒烟和尼古丁脱瘾市场报告涵盖的国家包括德国、瑞典、波兰、丹麦、意大利、英国、法国、西班牙、荷兰、比利时、瑞士、土耳其、俄罗斯和欧洲其他地区。

英国在欧洲戒烟和尼古丁戒瘾市场占据主导地位,利用高创新和产品开发。这培养了庞大的客户群。由于对无尼古丁替代品的偏好增加,对含尼古丁产品的需求正在上升。

在德国,由于产量增加以及对不含尼古丁的替代品的偏好日益增加,对含尼古丁产品的需求正在上升。

由于吸烟相关疾病发病率上升,民众意识增强,法国对含尼古丁产品的需求不断增长。

报告的国家部分还提供了影响市场当前和未来趋势的各个市场影响因素和市场监管变化。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测各个国家市场情景的一些指标。此外,在提供国家数据的预测分析时,还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的大量或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。

竞争格局和欧洲戒烟及尼古丁脱瘾市场份额分析

欧洲戒烟和尼古丁戒瘾市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对欧洲戒烟和尼古丁戒瘾市场的关注有关。

欧洲戒烟和尼古丁脱瘾市场的一些主要参与者包括:

  • Cipla Inc.(印度)
  • 强生服务公司(美国)
  • 武田药品工业株式会社 (日本)
  • Alkalon A/S(丹麦)
  • 22nd Century Group, Inc.(美国)
  • 葛兰素史克公司(英国)
  • 帝国品牌有限公司 (英国)
  • JT International SA(日本)
  • 英美烟草公司 (英国)
  • Perrigo Company plc(爱尔兰)
  • Fertin Pharma(丹麦)
  • Cambrex 公司 (美国)
  • Dr. Reddy's Laboratories Ltd.(印度)
  • 辉瑞公司(美国)
  • Strides Pharma Science Limited(印度)


SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

研究方法

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

可定制

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

The Europe Smoking Cessation and Nicotine De-Addiction Market size will be worth USD 107.57 billion by 2031 during the forecast period.
The Europe Smoking Cessation and Nicotine De-Addiction Market growth rate is 25.3% during the forecast period.
The Government Regulations for Smoking Cessation Products and Rapidly Evolving Social Norms Towards Quitting are the growth drivers of the Europe Smoking Cessation and Nicotine De-Addiction Market.
The product type, treatment type, form, distribution channel, and end-user are the factors on which the Europe Smoking Cessation and Nicotine De-Addiction Market research is based.
The major companies in the Europe Smoking Cessation and Nicotine De-Addiction Market are Cipla Inc. (India), Johnson & Johnson Services, Inc. (U.S.), Takeda Pharmaceutical Company Limited (Japan), Alkalon A/S (Denmark), 22nd Century Group, Inc. (U.S.), GSK plc. (U.K.), Imperial Brands plc (U.K.), JT International SA (Japan), BAT (U.K.), Perrigo Company plc (Ireland), Fertin Pharma (Denmark), Cambrex Corporation (U.S.), Dr. Reddy’s Laboratories Ltd. (India), Pfizer Inc. (U.S.), Strides Pharma Science Limited (India).